19.12.2012 Views

Anemia of Prematurity - Portal Neonatal

Anemia of Prematurity - Portal Neonatal

Anemia of Prematurity - Portal Neonatal

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

o There is speculation that birth defects in IDMs may be related to reduced<br />

arachidonic acid and myoinositol levels and elevated sorbitol and trace metal levels<br />

in the fetus.<br />

o Others speculate about the role <strong>of</strong> excess oxygen radicals and hydroperoxides in<br />

the mitochondria <strong>of</strong> susceptible fetal tissues because these prostacyclin inhibitors<br />

may cause disruption in the vascularization <strong>of</strong> developing tissues.<br />

o A past history <strong>of</strong> LGA infants, diabetes, stillbirth, hypertension, gestational diabetes,<br />

obesity, or glycosuria, or a current history <strong>of</strong> excessive weight gain in the present<br />

pregnancy or low socioeconomic class place the mother at an increased risk <strong>of</strong><br />

poor glucose control during pregnancy and increase her risk <strong>of</strong> delivering an infant<br />

with subsequent complications.<br />

• Fetal macrosomia<br />

o IDMs experience higher levels <strong>of</strong> glucose during gestation, resulting in pancreatic<br />

beta cell hyperplasia with increased secretion <strong>of</strong> insulin and proinsulin factors (IGF-<br />

1, IGF-BP3). Amino acid availability also is increased. All <strong>of</strong> these factors are<br />

involved in the excessive growth observed in the infants <strong>of</strong> diabetic mothers.<br />

o All organ systems, aside from the kidney and brain, are sensitive to the increased<br />

glucose and amino acid pools. Increased insulin levels result in an increase in cell<br />

number and cell size.<br />

• Impaired fetal growth<br />

o The major cause <strong>of</strong> impaired fetal growth is maternal diabetic nephropathy.<br />

Maternal vascular disease compromises uteroplacental blood flow and impairs fetal<br />

nutrient supply.<br />

o IDMs are at increased risk <strong>of</strong> preterm labor, stillbirth, neonatal death, birth injury,<br />

and perinatal asphyxia.<br />

• Pulmonary disease<br />

o These infants are at increased risk for respiratory distress syndrome, transient<br />

tachypnea <strong>of</strong> the newborn, and persistent pulmonary hypertension.<br />

o Insulin restricts substrate availability for surfactant biosynthesis and interferes with<br />

the normal timing <strong>of</strong> glucocorticoid-induced biosynthesis.<br />

o Insulin also blocks cortisol action at the fibroblast level by reducing production <strong>of</strong><br />

fibroblast-pneumocyte factor, which normally would stimulate type II cells to<br />

produce surfactant.<br />

o Several studies agree that the risk <strong>of</strong> respiratory distress syndrome in wellmanaged<br />

diabetic women delivered at term is no higher than in the general<br />

population.<br />

• Electrolyte abnormalities<br />

o These infants are at high risk for hypoglycemia, especially within the early hours<br />

after birth.<br />

o High levels <strong>of</strong> fetal insulin with cessation <strong>of</strong> continued maternal glucose supply take<br />

place after birth. The neonatal shift to gluconeogenesis with fatty acid use may<br />

provide an insufficient supply <strong>of</strong> substrate, and, thus, the infant may experience<br />

hypoglycemia (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!